The biopharmaceutical and broader biotechnology industries represent some of the most technically demanding, high impact commercial employers in the United States and worldwide, in terms of a highly compensated, highly educated workforce, and a driver of scientific innovation and economic prosperity. There are numerous long-standing, industry-wide challenges in terms of fundamental scientific and engineering problems that occur during the Development and Manufacturing stages for pharmaceutical proteins as they progress from Discovery to clinical trials, as well as during final commercialization. The newly formed Center for Biomanufacturing Science and Technology brings together faculty at the University of Delaware that tackle a wide array of problems and fundamental challenges in areas ranging from: cell culture processes and bioreactors; high-end and scalable purification processes; product formulation and stability; drug delivery; manufacturing; and analytical technologies, instrumentation, and algorithms to support all of these areas. The Center supports cutting edge research facilities on campus, educational activities including seminars, workshops, and shortcourses, as well as industrial research consortia. Many of the faculty in the Center have long-standing collaborations with biotechnology companies, and there are multiple avenues available for industrial collaborators to become involved with research and educational activities in the CBST.
Learn More
We invite you to learn more about our Center. Requests for additional information may be addressed to:
Director, Center for Biomanufacturing Science and Technology
University of Delaware
Department of Chemical & Biomolecular Engineering
Colburn Laboratory
Phone: (302) 831-0838 • Fax: (302) 831-1048
Email: cjr@udel.edu
Learn More about the Biomolecular Interaction Technologies Center
